Lite Strategy (LITS) vs NanoViricides (NNVC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
NanoViricides (NNVC) has outperformed Lite Strategy (LITS) over the past year, gaining 1.4% versus a loss of 48.2%. Over five years, NNVC leads with a -70.5% price change compared with -97.8% for LITS. Lite Strategy is the larger company by market cap ($37.1 million vs $33.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LITS | NNVC |
|---|---|---|
| Share price | $1.22 | $1.31 |
| Market cap | $37.10M | $33.44M |
| 1-day change | -3.94% | -9.03% |
| YTD return | -3.79% | +27.43% |
| 1-year return | -48.16% | +1.41% |
| 5-year return | -97.82% | -70.49% |
| EPS (TTM) | $-2.06 | $-0.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.97 | $2.23 |
| 52-week low | $0.69 | $0.85 |
| Distance from 52-week high | -58.92% | -41.26% |
| Average volume | 448.62K | 447.15K |
| Shares outstanding | 30.41M | 25.52M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NNVC has outperformed LITS by 49.6 percentage points over the past year.
LITS vs NNVC FAQ
Which is bigger, Lite Strategy or NanoViricides?
Lite Strategy (LITS) is larger, with a market capitalization of $37.10M compared with $33.44M for NanoViricides (NNVC).
Which stock has performed better over the past year, LITS or NNVC?
NNVC returned +1.41% over the past 12 months, compared with -48.16% for LITS (price return, excluding dividends). Past performance does not predict future results.
Are Lite Strategy and NanoViricides in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.